Evidence map›Paper›PMID 29162951›Full record

ReviewJournal of obstetrics and gynaecology of India2017

Down Syndrome Screening in India: Are We There Yet?

K Manikandan, Suresh Seshadri

Abstract readReview
In one paragraph

Review in Journal of obstetrics and gynaecology of India, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Comment on Two Recent Invited Mini-reviews.Journal of obstetrics and gynaecology of India · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

K ManikandanDepartment of Fetal Medicine, Mediscan Systems, 197, Dr Natesan Road, Mylapore, Chennai, 600 004 India.ORCID 0000-0002-1234-4818
Suresh SeshadriDepartment of Fetal Medicine, Mediscan Systems, 197, Dr Natesan Road, Mylapore, Chennai, 600 004 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Down syndrome is the most common cause of intellectual disability among live born children and is amenable to prenatal detection. Screening for Down syndrome on a population basis requires a thorough understanding of the principles involved in the screening tests. We discuss the rationale behind the commonly available screening tests and the Indian scenario in this setting.

Indexed as

Combined screening testDown syndromeIndian scenarioPrenatal screeningQuadruple screening test

Identifiers

PMID29162951
PMCPMC5676577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.